BioSpace News Archive

Approval also includes extending the Nucleus 7 Sound Processor to the first U.S. cochlear implant recipients, Custom Sound Pro fitting software to enhance support for hearing professionals

Varian (NYSE: VAR) today announced it received the “Best After-Sales Service Award for Radiotherapy Products” in the 2019 Chinese Medical Devices Industry Data and After-Sales Service Survey for the third year in a row. Varian also led in metrics of Market Share, Repurchasing Reference, and Net Promoter Score. The 1

Adial Pharmaceuticals, Inc. today announced that it has received approvals in Sweden and Estonia to commence the Company’s landmark ONWARD™ pivotal Phase 3 clinical trial to investigate its lead drug candidate, AD04, as a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes.

Data from Phase 3 LIBERTY program show improvement in patient-reported outcomes in addition to improvement in hemoglobin levels in anemic women Detailed data from ovulation inhibition study demonstrate 100% ovulation inhibition and 100% return of ovulation upon treatment discontinuation Findings presented during European Society of Human Reproduction and Embryology (ESHRE) virtual 36th Annual Meeting taking place July 5-8, 2020

Global biotherapeutics leader CSL Behring today announced that the first patient has been enrolled in its Phase 2 study to assess the safety and efficacy of CSL312 (garadacimab, Factor XIIa antagonist monoclonal antibody) to treat patients suffering from severe respiratory distress, a leading cause of death in patients with COVID-19 related pneumonia.

A significant proportion of patients undergoing cancer therapy experience diarrhea.

Avanti combining with Croda to expand life sciences products, pharmaceutical services and cGMP production capabilities for biotechnology, pharmaceutical and life science research customers globally Avanti will continue to operate under the Avanti brand and be led by the current management team [06-July-2020] ALABASTER, Alabama , July 6, 2020 /PRNewswire/ --

The Coalition for the Advancement of Research and Innovation in Trauma (CARIT) announced today the addition of Prytime Medical Inc. (Prytime).

Echosens , a high-technology company offering the FibroScan family of products, announces today that the National Institute for Health and Care Excellence ( NICE ), the United Kingdom’s health technology assessment body providing national guidance and advice to improve health and social care, issued a MedTech Innovation Briefing (MIB) dedicated to utilization of FibroScan non-invasive technology in the primary

Havn Life Sciences Inc. (the “Company” or “Havn Life”), announces the appointment of Gary Leong as Chief Science Officer of Havn Life. Mr. Leong has over thirty (30) years of experience in the Pharmaceutical and Natural Health Products (“NHP”) industry.